Next, 1 unit of Toq polymerase was added and a 2-min extension was carrled out at 72~ followed by 33 amplification cycles using denaturing, annealing, and extension temperatures and times optimal for each primer set. Then, 35 I~1 of each reaction was run on 8% acrylamide gels directly or 1% agarose gels following digestion; genotypes were Inferred by ethidlum bromide staining of gels. Guthrle blood spots of 250 CF probands and their parents were screened and the frequencies of all five mutations as well as the XV-2C KM-19 RFLP hapIotypes were determined. Our data Indicate: (1) direct PCR amplification provides a simple, rapid, and inexpensive method to determine CF genotypes directly from dried blood spots and (2) these methods provide special advantages regarding ease and convenience of sample collection, shipment, analysis, and storage Dried blood spot technology facilitated the historical development of neonatal screening programs. The recent identification of the most common cystic fibrosis (CF) mutation, the deletion of the phenylalanine codon at position 508 (F508) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, has allowed rapid molecular genetic analysis of CF patients. With the continuing characterization of new mutations within the CFTR gene, there will be a demand to identify simultaneously carriers of the most prevalent mutations. In the United States, the most common CF alleles are F508, G551D, G542X, R553X, and N1303K. These mutations comprise 85% of U.S. CF alleles, and their identification combined with analysis of XV-2C and KM-19 RFLPs can enable determination of CF status. We developed methods to detect directly each of these mutations and RFLPs by direct PCR amplification of a small piece of a single dried blood spot collected on newborn screening cards. These methods are rapid and accurate and facilitate sample collection, shipment, and storage.
In the United States the most common cystic fibrosis (CF) alleles known are F$08, G$$1D, G$42X, R$S3X, and N1303K. These mutations comprise -85% of U.S. CF alleles, and their detection along with analysis of XV-2C and KM-19 restriction fragment length polymorphisms (RFLPs) can enable the determination of CF status. To facilitate studies for determining CF carrier status, we developed methods to dete(t each of these mutations and RFLPs by direct PCR amplification of dried blood spots collected on newborn screening (Guthrle) cards. Following collection, samples were protected from contamination by individual plastic bags. One-mm z segments of filter paper were added directly to 100-1~1 PCR reactions containing 1/16 mM spermidine. Three Initial cycles at 96~ then $$~ for 3 min were performed to free DNA and minimize inhibition by other related materials.
Next, 1 unit of Toq polymerase was added and a 2-min extension was carrled out at 72~ followed by 33 amplification cycles using denaturing, annealing, and extension temperatures and times optimal for each primer set. Then, 35 I~1 of each reaction was run on 8% acrylamide gels directly or 1% agarose gels following digestion; genotypes were Inferred by ethidlum bromide staining of gels. Guthrle blood spots of 250 CF probands and their parents were screened and the frequencies of all five mutations as well as the XV-2C KM-19 RFLP hapIotypes were determined. Our data Indicate: (1) direct PCR amplification provides a simple, rapid, and inexpensive method to determine CF genotypes directly from dried blood spots and (2) these methods provide special advantages regarding ease and convenience of sample collection, shipment, analysis, and storage Dried blood spot technology facilitated the historical development of neonatal screening programs. The recent identification of the most common cystic fibrosis (CF) mutation, the deletion of the phenylalanine codon at position 508 (F508) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, has allowed rapid molecular genetic analysis of CF patients. With the continuing characterization of new mutations within the CFTR gene, there will be a demand to identify simultaneously carriers of the most prevalent mutations. In the United States, the most common CF alleles are F508, G551D, G542X, R553X, and N1303K. These mutations comprise 85% of U.S. CF alleles, and their identification combined with analysis of XV-2C and KM-19 RFLPs can enable determination of CF status. We developed methods to detect directly each of these mutations and RFLPs by direct PCR amplification of a small piece of a single dried blood spot collected on newborn screening cards. These methods are rapid and accurate and facilitate sample collection, shipment, and storage.
METHODS
Following collection, samples were protected from contamination by placing them in individual plastic bags. A small piece (1 mm 2) was cut from each filter paper blood spot and added directly to a 100-1~1 PCR reaction containing 1/16 mM spermidine; 1 mM of each oligonucleotide primer flanking the exon or intron relevant for each mutation or polymorphism; 10 mM Tris (pH 8.0); 50 mM KC1; 1.5 mM MgCl2; 0.001% gelatin; and 200 mM of each deoxynucleotide phosphate. (7) Instead of heating the samples 6 min at 94~ as usual for genomic DNA templates, the whole PCR reaction was heated for 3 min at 96~ and then cooled for 3 min at 55~ This two-step incubation was repeated three times to free DNA and minimize inhibition by released proteins and heavy metals. ~8) Next, 1 unit of Taq polymerase was added and a 2-min extension was done at 72~ followed by 33 amplification cycles using denaturing, annealing, and extension temperatures and times optimal for each primer set. (3-6'7'8) Upon completion, a 10-rain extension period was done at 72~ and the products were cooled on ice. Next, 35 l~l of each reaction mixture were run directly on nondenaturing polyacrylamide gels in 1• TBE (Tris-borate-EDTA, pH 8.0) for 1 hr at 100 mV and 2 hr at 300 mV, directly (F508), or in 1% Seakem Agarose (FMC) following restriction endonuclease digestion (G551D, R553X, KM19, and XV2C). Genotypes were inferred following ethidium bromide staining of gels and exposure to UV light. G542X and N1303K were detected by allele-specific hybridization techniques, following standard protocols. (s'6) Guthrie blood spots of 250 CF probands and their parents were screened, and the frequencies of all five mutations as well as the XV2C/ KM19 RFLP haplotypes were determined. 
RESULTS
We have derived conditions that enable specific and reproducible amplification of segments of the CFTR gene that contain five different mutations and two RFLPs. These conditions included (1) using three initial denaturing/annealing cycles of 96~ and 55~ and adding the enzyme after the incubation step; (2) adding spermidine or Chelex to the PCR amplification reactions; and (3) increasing the number of PCR cycles (see Fig. 1 ).
Conditions designed to optimize the yield were used to amplify segments of the CFTR gene that contain the F508, G551D, R553X, G542X, and N1303K mutations as well as as the KM19 and XV2C RFLPs (see Figs. 2-5) . Analysis of 750 blood spot samples from 250 CF probands and their parents were done. The yields of PCR amplification products from filter paper-derived and isolated genomic DNA were very similar and no discrepancies in genotypes were noted among the 250 patient samples analyzed from both types of templates.
DISCUSSION
The use of dried blood spots for CF analysis has been previously reported by other investigators. (9-12) The microextraction procedure previously described (9'1~ is personnel intensive and therefore would be a costly component of any high-volume DNA diagnostic program based on dried blood spots. Nelson et al. (1') described a procedure that incorporates the need for incubation and boiling the samples, which is time-consuming and may lead to contamination. In our hands, we could not get the same specificity and sensitivity compared to our method. The procedure described by Schwartz et al. for the phenylketonuria gene (lz) used a constant heating of the FIGURE 2 Agarose gel electrophoresis of patient samples assayed for G551D and R553X mutations. (Lanes 1 and 14) ~X174/HaelII molecular weight markers; (lanes 2-12 and 16--25 ) patient samples digested with HinclI. The larger, uncut fragment in lane 19 may correspond to the G551D or R553X mutations. This sample was subsequently digested with MboI and found to be heterozygous for the G551D mutation; the rest of the samples are homozygous for the normal allele. Lane 13 is a negative control (no DNA). sample for 7 min at 97~ and in our hands gave a reliable yield only for amplification of small PCR fragments, which would be useful for the detection of F508 (98 bp) but not for the other mutations and polymorphisms. Using our protocol, we were able to amplify fragments as large as 2000 bp (data not shown) starting from a small piece of filter paper.
We have developed a method for detecting five CFTR gene mutations and two RFLPs from a single spot on a Guthrie card (Figs. 1-5) . A total of 750 samples were evaluated with this o p t i m u m protocol and our results indicate that PCR reaction yields can be increased by the use of three initial denaturing/annealing cycles of 96~ and 55~ and adding the enzyme after the incubation step, addition of spermidine or Chelex to the PCR amplification reactions, and increasing the number of PCR cycles. Two advantages of this method are that it: (1) eliminates the need for tedious and time-consuming methods for extracting DNA from individual blood spots, and (2) increases the number of potential mutations that can be determined from a single card. Our results demonstrate that direct PCR amplification from Guthtie blood spots can provide a rapid, simple, and inexpensive method to screen directly for the presence of 85% of CF alleles in the United States and to estimate the carrier status for the remaining 15% of CF alleles. On the basis of the size of the average blood spot on a Guthrie card, more than 25 alleles of CFTR could potentially be screened from a single blood spot. Thus, this method coupled with multiplex CF mutation screening methods theoretically should enable numerous mutations to be detected on a single lane of an acrylamide gel, starting from a small piece of a single dried blood spot, without using radioactive isotopes.
The efficiency and yield of PCR amplification using filter paper is increased by alternating heating and cooling steps. (2) A single longer heating incubation or different times and temperatures of the heating-cooling cycle resulted in poor amplification. Adding the enzyme immediately after the incubation step prevents pre-PCR mispriming and primer dimerization and improves the amplification of genes that occur in low copy number. (a3) Adding larger amounts of filter paper was detrimental to the PCR reaction, probably because of the FIGURE 3 Slot-blot hybridization analysis of PCR-amplified products using allele-specific oligonucleotide probes for the G542X mutation. Patient samples numbered 35, 37, and 42 are heterozygous for the mutant allele whereas the remainder are homozygous for the normal allele. Use of direct PCR analysis of Guthrie blood spots offers significant advantages over other screening methods, including reduction of the time needed, therefore increasing the n u m b e r of samples that could be h a n d l e d conveniently. This approach may be automated, using direct automated sequencing by asymmetric PCR, (is) and thereby increasing the feasibility of large-scale screening for CF.
